Abstract | Persistently elevated oxidative stress and inflammation precede or occur during the development of type 1 or type 2 diabetes mellitus and precipitate devastating complications. Given the rapidly increasing incidence of diabetes mellitus and obesity in the space of a few decades, new genetic mutations are unlikely to be the cause, instead pointing to environmental initiators. A hallmark of contemporary culture is a preference for thermally processed foods, replete with pro-oxidant advanced glycation endproducts (AGEs). These molecules are appetite-increasing and, thus, efficient enhancers of overnutrition (which promotes obesity) and oxidant overload (which promotes inflammation). Studies of genetic and nongenetic animal models of diabetes mellitus suggest that suppression of host defenses, under sustained pressure from food-derived AGEs, may potentially shift homeostasis towards a higher basal level of oxidative stress, inflammation and injury of both insulin-producing and insulin-responsive cells. This sequence promotes both types of diabetes mellitus. Reducing basal oxidative stress by AGE restriction in mice, without energy or nutrient change, reinstates host defenses, alleviates inflammation, prevents diabetes mellitus, vascular and renal complications and extends normal lifespan. Studies in healthy humans and in those with diabetes mellitus show that consumption of high amounts of food-related AGEs is a determinant of insulin resistance and inflammation and that AGE restriction improves both. This Review focuses on AGEs as novel initiators of oxidative stress that precedes, rather than results from, diabetes mellitus. Therapeutic gains from AGE restriction constitute a paradigm shift.
Introduction
The incidence of type 2 diabetes mellitus (T2DM), and increasingly T1DM, continues to surge despite many therapeutic advances. Diabetes mellitus is now the lead ing cause of cardiovascular, renal and other serious comorbidities in old but also young adults. [1] [2] [3] [4] [5] The pan demic proportions of the problem make it imperative that new etiologic factors and effective, lowcost therapeutic interventions are identified. The pathogenesis and demo graphics of diabetes mellitus are complex, but mount ing evidence suggests that the environment, namely socioeconomic and behavioral etiologies, potentiates or even supersedes genetic susceptibility. 6 Elevated oxida tive stress appears to precede the development of both T1DM and T2DM and their sequelae, which indicates a weakening of host defense mechanisms over time. 7 Hyperglycemia was long thought to be the single major cause of oxidativestressdriven diabetic complications. 8 How ever, once diabetes mellitus is established, strict control of hyperglycemia was beneficial for some comor bidities, such as retinopathy and nephropathy, but proved less effective against macrovascular disease, with a high mortality caused by macrovascular complications. [8] [9] [10] [11] Major antioxidant trials have yet to markedly reduce the incidence of diabetes mellitus or conditions that precede this disorder, such as obesity and the metabolic syndrome, 12 which suggests that the presence of high pre existing (or basal) oxidative stress may be underestimated in both severity and duration. This hypothesis is strongly supported by evidence that reveals a high prevalence of cardiometabolic risk factors clustered in individuals with a normal phenotype but with unexplained high oxidative stress and inflammation. 13, 14 A comprehensive search for new initiators of oxidative stress has led to reevaluation of the environment and revealed a crucial link between a positive energy balance and deleterious outcomes, such as obesity and diabetes mellitus. Although the modern diet is thought to under lie both types of diabetes mellitus, as well as pre diabetes and cardiovascular disease, the diabetogenic culprits within the diet remain a subject of debate. [15] [16] [17] [18] We have proposed that the modern (Western) nutritional environ ment, although it provides adequate energy, is replete with oxidants that promote an abnormal oxidative stress state. [19] [20] [21] Advanced glycation endproducts (AGEs) and advanced lipoxidation endproducts (ALEs) represent a class of prooxidants in foods, the presence of which is promoted by food processing at high temperatures. [22] [23] [24] [25] [26] [27] AGEs also serve as 'appetiteenhancing' agents that simul taneously spur overnutrition, inflammation, obesity and diabetes mellitus.
In this Review, insights from studies of humans and mice are discussed with an emphasis on the effects of exogenous AGEs and the suppression of specific factors of host defense mechanisms. The loss of these defenses is proposed to be the driving force behind the increased oxidative stress and the pathogenesis of both T1DM and T2DM and their complications. New cellprotective li aisons between cellular AGE receptors (AGER1) and the NAD + dependent deacetylase sirtuin 1 (SIRT1)-two components of a complex and powerful homeo stasis system-are highlighted. An imbalance between host defenses and increased oxidant challenges from the environ ment may form the basis of the incipient cell injury that underlies diabetes mellitus. AGE restriction is intro duced as a novel costefficient strategy in the prevention and treatment of the current diabetes epidemic.
Origin of AGEs and ALEs
AGEs are known to modulate a multitude of intra cellular and extracellular structural and prooxidant effects, includ ing inflammation, cell proliferation or apoptosis, as well as insulin signaling in organs as varied as islet β cells, blood vessels, kidneys and brain. 16, 17, [29] [30] [31] AGEs are prooxidant metabolic derivatives of nonenzymatic reactions between reducing sugars and free amines of proteins, largely αNH 2 or εNH 2 groups of proteins, as well as of aminolipids and nucleic acids. 29, [32] [33] [34] Extracellular and intracellular reactive carbonyl precursors, such as glyoxal, 3deoxyglucosone or methylglyoxal derivatives, 29 readily react with proteins or lipids to generate oxidants, namely Nεcarboxymethyl lysine (CML), or crosslinkforming endproducts, for example, pentosidine. 29, 32, 35, 36 These processes permanently alter connective tissue proteins, plasma lipoproteins, cell membrane phospholipids or DNA. 16, 17, [37] [38] [39] The chemical process of glycation, also known as Maillard reaction, 40 is exquisitely sensitive to pH, temperature, hydration, type of sugar and acid or base buffering conditions; it is slow and strictly regulated in vivo. However, under super physiological conditions, AGEs form at vastly accelerated rates, dependent on source (animal or plant), time and temperature applied. 22, 25, 26, [41] [42] [43] AGEs in nutrients are similar to those found in animal or human tissues and comprise mixtures of reactive and nonreactive AGEs that share biochemical, immunochemi cal and molecular properties. 23, 44, 45 Reactive AGEs can promote the generation of new AGEs and reactive oxygen species (ROS), deplete antioxidant systems and elicit secre tion of inflammatory mediators. 23 Assessment of AGEs now relies on sensitive immunoassays for certain AGEs which have been characterized by highpressure liquid chromatography, gas chromatography and mass spectrom etry, such as CML or the methylglyoxalderived hydroimi dazolone. 23, 28, 32, 35 These products are neither unique nor the most prevalent AGEs, but they are common in vivo and correlate well with native oxidants, such as 8 isoprostanes, or their bioactivities. 20, 21, 23 CML and methylglyoxal derived hydroimidazolone are, therefore, currently among The role of fatty acids in the pathogenesis of dia betes mellitus and insulin resistance has been well established; 48 however, AGEs formed from lipids have not been widely recognized as a source of ROS. Glucosederived glycolytic intermediates can readily form on amine containing lipids, such as phosphatidyle thanolamine, which generates ALEs, ROS and peroxidized fatty acids, that is, 4 hydroxynonenal and malondialdehyde. 37, 49, 50 Thus, AGE modification of the apoprotein or the lipid particle of apolipo protein B (ApoB) can delay receptormediated LDL cholesterol removal, 49 which may increase levels of highly atherogenic AGE-LDL in plasma or the blood vessel wall, even if the plasma lipid profile appears normal. 51 Over the past decade, it has become apparent that the interactions between AGEs and ALEs are far more prevalent in vivo than previously estimated. Substantial amounts of nonenzymatically oxidized lipids are orally absorbed 52, 53 or generated from AGE precursors. 54 Unsatu rated fatty acids, mostly from exogenous sources, can act as major donors of reactive carbonyls and are more effi cient catalysts of AGE or ALE production than is glucose. Paradoxically, these facts have escaped serious attention. Given that ALEs also interact with AGE receptors, these compounds could underlie phenomena currently attrib uted to free fatty acids, such as insulin resistance and atherosclerosis. AGEs may also play a major part in athero sclerosis, 54, 55 as the very low af finity of fatty acids for recep tors (that is, tolllike receptor 4 [TLR4]) does not suggest a role for fatty acids at circulating levels. [56] [57] [58] Intracellular AGE formation is naturally slow, partly regulated by the balance between nascent oxidants and antioxidants 59 and partly by the glyoxalase system. [60] [61] [62] Extracellular AGEmodified proteins are sequestered by cellular or soluble AGE receptors, 30 degraded by proteolytic diges tion to soluble peptides, and are normally excreted by the kidneys. 63, 64 One reason for delayed AGE detoxification is that crosslinks of AGEs and proteins are resistant to degra dation, which delays their turnover and interferes with tissue repair. 35, 36 AntiAGE host defenses include suppres sion of signaling via the AGE receptor AGER1 and renal AGE elimination or detoxification. 65, 66 The link between decreased renal AGE excretion and chronic diabetes mel litus is poorly understood and may in part be a result of reduced renal AGER1 levels. 65, 66 Although native defense mechanisms are enormously adaptive, the high level of oxidants in the current nutritional environment may potentially exceed their efficiency and limits, especially in the presence of diabetes mellitus. 19 
AGEs in nutrients: a modern Trojan horse
Obesity, a condition found to be inflammatory, 56 is associ ated with an 'imbalance' in native defenses, 59 ,67 defined as a surplus of unopposed ROS. Food is quantitatively the largest environmental factor in direct contact with host defenses. Deviating from nutrientbased views that propose that excess nutrients can cause increased oxida tive stress (Figure 1a) , it has been suggested that ROS promoting substances enter the body with processed foods in the form of embedded AGEs (Figure 1b) . [19] [20] [21] 23, 25, 27, 28 The burgeoning presence of toxic AGEs in modern food stuffs has resulted from vast socio economic changes in the past 50 years and new technologies employed in the mass production of food. 43, 68, 69 At the simplest level, this change involves heat and dehydration, as well as ionization or irradiation. These processes, though intended to improve safety and transportability of foods, amplify glycoxidation reactions and the formation of AGEs and ALEs. Initially, an increased amount of AGEs in food was considered to be desirable, given the effect of AGEs on food flavor. 68, 70 Approximately 10% of a single AGErich protein prepa ra tion is orally absorbed by humans. 19 This propor tion was confirmed by kinetic studies in normal rats, using orally administered doublelabeled AGE tracers ( 121 I-14 C glucosederived AGE-ovalbumin), to separate exogenous from native AGEs, and an AGE inhibitor, amino guanidine, to block interference from AGEs formed de novo. 71 AGEs were absorbed mostly as a single peptide, dipeptides or tripeptides, and approximately twothirds remained in contact with tissues for >72 h, whereas the rest was rapidly excreted by the kidneys. Based on these kinetic studies, the rate of tissue AGE accumulation due to carbonyls in nutrients was estimated to be an order of magnitude greater than that due to endogenous metabolites, glucose or lipids.
The actual effect of sustained exposure to foodderived AGEs was evaluated in a series of studies in mice. Dia betic, ApoEdeficient, hyperlipidemic or aging mice were exposed to either a regular diet or a diet with a lower amount of AGEs (referred to as an AGErestricted diet), while both groups of mice were kept under normal energy balance. Importantly, mice on the AGErestricted diet did not develop severe diabetic tissue injury despite an excess of metabolites, such as glucose or lipids, either as single or as combined entities (Box 1). [72] [73] [74] [75] [76] Namely, development of diabetic vasculo pathy and nephropathy appeared to be dependent on the glycoxidants, including ALEs, present in regular animal food. This provocative interpretation was confirmed by more direct studies in which a single synthetic preAGE, methylglyoxalmodified albumin, was added to an AGErestricted mouse diet. 73 The significant increases in systemic AGE levels and oxidative stress in methylglyoxalfed mice supported the postulate that chronic ingestion of excessive amounts of AGEs influ ences oxidative stress balance and alters the cellular and metabolic phenotype of these animals, as well as that of their progeny.
These data may have direct relevance to humans, given the marked expansion of processed foods in the past 50 years and the close relationship of AGEs to food flavor. It is safe to conclude that the consumption of thermally altered AGErich foods has also greatly increased during this time. This behavioral change may potentially have contributed to both overnutrition, causing obesity, and to oxidant overload, leading to inflammation ( Figure 1a ,b), and may partially explain the paradoxical coexistence of good energy balance (positive) and inflammation (negative) that precede diabetes mellitus and related ca rdiometabolic disturbances.
Host defenses
The host defense system employs numerous mecha nisms to restrict AGE toxicity. Along with degradation of AGEs and antioxidant systems, AGE receptors are a major part of the innate and adaptive responses utilized to avoid or regulate the predominantly adverse effects of these molecules. 17, 30 At least two classes of AGE receptors exist: AGER1, which suppresses AGEs and AGErelated ROS and inflammation, and RAGE, which propagates these effects. [77] [78] [79] [80] Ideally, AGER1 opposes or intercepts the proinflammatory effects of RAGE and maintains AGE homeostasis. [79] [80] This defense mechanism is lost in patients with diabetes mellitus, namely AGER1 acti vity is suppressed, which contributes to the production of further AGEs, ROS and hence tissue injury.
Protection against diabetes mellitus is among the sug gested properties of AGER1, based on findings in AGER1 transgenic mice or wildtype mice fed AGErestricted, AGEsupplemented diets or calorierestricted mice. [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] Increased AGER1 expression is associated with extended lifespan in mice, 72 a finding which may be due to a syner gism with SIRT1, a deacetylase with strong links to both antiinflammatory and proinsulin actions. 82, 83 AGER1 and SIRT1 are suppressed in conditions linked to the oxidant overload that is present in diabetes mellitus, overnutrition and aging. 72, [84] [85] [86] The coordinated downregulation of these two cellprotective systems, as well as of downstream positive effector pathways, may be the result of a single cause, a sustained and largely unopposed supply of oxi dants. Once these first order host defenses are impaired, basal oxidative stress would be expected to increase above the level required for normal cellular functions, and the surplus ROS could trigger inflammation in the pancreas, βcell injury and peripheral insulin resistance. This view is supported by human and animal data showing that sustained and longterm reduction of surplus ROS-that is, by lowering foodderived AGE consumption without altering energy or nutritional balance-restores host defenses, 21 basal oxidative stress and ameliorates abnor mal transcriptional factor activity (NFκB or forkhead box protein O [FOXO]). 87 The net effect in vivo is increased tissue resistance to injury and resetting of the threshold for normal insulin actions. 72, 73 AGE receptors Elucidation of AGE interactions with AGE receptors has proven complicated. First, the receptors have a rela tively low binding affinity. Second, the ligands have a high versatility in terms of structure or charge. Third, AGEs can signal through nonAGE receptors, such as scaven ger receptors, Gproteincoupled receptors, pattern recognition receptors and TLRs, as well as via receptor independent pathways. In addition, their mode of engagement is not completely known. Finally, under sustained AGE ligand excess, levels of AGE receptors are differentially regulated. For instance, AGER1, along with other antioxidant systems and host defenses, is found to be depleted, suppressed or unresponsive, whereas RAGE is upregulated in high oxidative stress states.
In addition to the better known AGE receptors discussed below, many other receptors interact with AGEs, including scavenger receptor class A type 2 (SCARB2), platelet glyco protein 4 (CD36), AGER3 (encoded by the gene LGALS3) or soluble proteins known to be parts of anti microbial defenses, such as lysozyme and defensins. 30, 89, 116, 117 The evidence reviewed below emphasizes the complexity and abundance of pathways that are responsive to, regulated by and possibly obscured by chronic exposure to excessive amounts of environmental AGEs.
AGER1-defense against AGE toxicity
AGER1, which is encoded by the gene DDOST, is an evolu tionarily conserved type 1 transmembrane protein, critically involved in protein synthesis, AGE turnover, regulation of ROS and cell survival. 79, 80, 87, 88 This ~50 kD AGEbinding protein is present on most cells, includ ing macrophage and mononuclear cells, and mediates the uptake, degradation and disposal of AGEs from cells and tissues. 79, 89, 90 Although first identified in the endo plasmic reticulum (as OST48), 91, 92 AGER1 is present on the plasma membrane and in sub cellular compartments. By sequestering and degrading AGEs, AGER1 prevents the accumulation of these molecules in the extra cellular milieu and the cytoplasm, which blocks the generation of ROS and new AGEs promoted by other receptors (RAGE, TLR4, EGFR, SCARB2, CD36) or by non receptor mechanisms. 16, 30, 67, [93] [94] [95] [96] In humans, AGER1 levels inversely correlate with intra cellular AGEs and directly with urine AGEs. 21 This relation ship curtails a series of AGEinduced cell destabilizing processes. Thus, AGER1 inhibits the activation of NADPH oxidases p47 phox (also known as neutrophil cytosol factor 1) and gp91 by suppressing Tyr311 and Tyr332 phosphory lation of PKCδ. 97 This action prevents the activation and nuclear translocation of NFκB p65 97 and of AGE res ponses that are promoted by RAGE. 98 As AGER1 also prevents AGEinitiated transactivation of EGFR in the presence of high oxidative stress, 80, 97 it may serve to restrict kinase hyper activity of other Gproteincoupled receptors. 99, 100 Of note, AGER1 inhibits AGEinduced Ser36 phosphory lation of the p66
Shc isoform of SHCtransforming protein 1, a major oxidative stress and apoptosispromoting adaptor protein. 87 This process merits attention, as increased levels of p66
Shc are linked to diabetes mellitus, atherosclerosis and kidney disease. 101 In addition, the deletion or mutation of the gene encoding p66
Shc extends lifespan in mice. 101, 102 Consistent with its role in the negative regulation of p66
Shc activity, AGER1 also inhibits AGEmediated suppression of the anti oxidant effect of FOXO3 on superoxide di smutase 2 (SOD2) expression. 87 Given that AGER1 deletion is lethal in yeast, the bio logical properties of AGER1 were confirmed by in vitro gene transfer and gene silencing studies. 79, 87, 92 Further more, in transgenic mice, high AGER1 levels prevented formation of occlusive atheromas caused by wireinjury, a high fatdiet or T2DM. 81 These studies helped unravel the potential in vivo significance of this antiAGE mecha nism in diabetes mellitus, given that it is suppressed in condition s of chronically elevated oxidative stress.
A potentially important protective synergism between AGER1 and the SIRT1 has been identified. 88 Of the numerous sirtuins, SIRT1 is thought to play a major part in insulin signaling and secretion, insulin resistance, inflam mation and lifespan. 82, 83 SIRT1, like AGER1, is suppressed in diabetes mellitus, highfat feeding and aging. 82, 84, 86 These conditions are also characterized by high levels of AGEs and oxidative stress. Of note, AGER1 over expression blocks AGEinduced suppression of SIRT1 via NAD + / NADH (H. Vlassara, unpublished work), 88 inhibiting NFκB p65 hyperacetylation and inflammatory events in monocytes and tryptophan 5hydroxylase 1 (TPH1) posi tive cells. Furthermore, AGER1 prevents AGEinduced impaired signaling via the insulin receptor and insulin receptor substrate 1 (IRS1) in adipocytes. 88 This action prevents an AGEinduced decrease in glucose uptake by adipocytes in vitro and in vivo. These data suggest that AGER1 provides a shield to SIRT1 against a high external oxidant load, thereby helping mitigate inflammation and preserve the metabolic actions of insulin (Figures 2 and 3) . The fact that AGER1 protein levels in peripheral blood mononuclear cells isolated from healthy humans are responsive to and correlate with circulating AGE levels supports this view. 21 After extended periods of exposure to high levels of AGEs, as in patients with diabetes mellitus and chronic kidney disease, AGER1 levels are suppressed. 20, 21, 85, 87 As AGER1 levels decrease, AGEs and ROS accumulate, Innate host defense cells, monocytes and macrophages normally bind, endocytose and degrade AGEs via the cell-surface AGER1 (also known as DDOST), the levels of which normally correlate inversely with intracellular levels of AGEs. Prolonged supply of external AGEs, however, depletes AGER1. Ensuing surplus ROS promotes inflammation via RAGE, TLR4, EGFR and other receptors regulating the activities of NFκB, AP-1, FOXO3 and other factors, via numerous pathways. These increase AGEs, ROS and inflammatory mediators, including RAGE and its ligands. AGEs, acting via ROS, are potent suppressors of NAD + , partly by reducing NAMPT and SIRT1 levels. Decreased SIRT1 levels promote NFκB p65 hyperacetylation and enhanced transcription of inflammatory genes consistent with an M1 macrophage profile. For instance, TNF induces an overlapping set of target genes, which contributes to insulin resistance. AGER1, by blocking AGEs, controls many of these effects. The protective effects of AGER1 may stem from its long extracellular tail with highaffinity AGE-binding, which competitively interferes with AGE-cell-surface interactions leading to ROS. This property may constitute the essence of the positive synergism between AGER1 and SIRT1. Though suppressed in humans and animals with chronic diabetes mellitus, monocyte/macrophage AGER1 and SIRT1 levels can be restored to normal following AGE restriction. Abbreviations: AGE, advanced glycation endproduct; AGER1, AGE receptor 1; EGFR, epidermal growth factor receptor; ERK1/2, extracellular signal-regulated kinase 1/2; FOXO3, forkhead box protein O3; MAPK, mitogen-activated protein kinase; MYD88, myeloid differentiation primary response protein MyD88; NAMPT, nicotinamide phosphoribosyltransferase; NFκB, nuclear factor κB; PKCδ, protein kinase C δ type; RAGE, receptor for advanced glycosylation endproducts; ROS, reactive oxygen species; SIRT1, NAD-dependent deacetylase sirtuin-1; TLR4, toll-like receptor 4; TNF, tumor necrosis factor.
feeding into a cycle of formation of new ROS and AGEs. Although the cause of AGER1 downregulation in dia betes mellitus is not evident, this effect is reversible by consumption of AGErestricted foods in both humans and mice. 21, 72, 73, 88 SIRT1 levels are also restored by AGE restriction, a fact which underscores the interdependence of these two pathways. The antiAGE activities of another AGEbinding molecule, serum lysozyme, resemble those of AGER1. 103 Lysozyme, an antibacterial protein, binds AGEs within a short cysteinebounded (ABCD) motif. Notably, both the antiAGE activity and antibacterial function of lysozyme are also decreased in patients with chronic diabetes mellitus. In summary, AGER1 expres sion levels correlate positively with levels of other intra cellular antioxidant mechanisms (for example, SIRT1, NAMPT, SOD2, GSH) and negatively with prooxidant pathways (that is, RAGE, NADPH oxidase, p66 shc ). If AGER1 is important in the maintenance of normal homeo stasis, then reduced AGER1 expression levels may signal a compromise in host defenses (Box 2). Similarly, the timely restoration of decreased AGER1 levels follow ing a medical intervention may also further the recovery of other important native defenses, a hypothesis which remains to be established.
RAGE-passive enabler of inflammation
RAGE action propagates ROS and inflammation in both acute and chronic diseases, including diabetes mel litus. [104] [105] [106] [107] RAGE is a member of a family of low affinity, patternrecognition receptors that function at the interface of innate and adaptive immunity and bind multiple ligands, including high mobility group protein B1 (HMGB1), amyloid β protein and members of the calciumbinding S100 protein group. [108] [109] [110] The binding conditions of AGEs by RAGE relative to these other ligands, in the initiation of signaling events in vivo, are not wellunderstood and even debated. 111 Whereas the fulllength molecule does not contribute to endo cytosis or removal of AGEs, the extracellular domains of RAGE may be shed as soluble variants and contribute to AGE clearance. 112 On the other hand, activation of fulllength cellassociated RAGE induces an array of signaling events, including MAPK p38-JNK and JAK-STAT, CDC42-RAC and others, many of which are the result as well as the cause of ROS. This apparent redundancy could be partly owing to the diversity of putative RAGE ligands or cell types involved and partly owing to the inter action of RAGE with other receptors, especially TLR4. A series of reports suggest that TLR2 and TLR4 levels are elevated in patients with diabetes mellitus and that they interact with AGEs, either directly or via RAGE and other RAGE ligands, such as HMGB1. 55, 109, 110, 113 Of note, inflam matory and vascular cells with either absent or defective TLR4s lack the typical inflammatory response to AGEs (H. Vlassara, unpublished work). Although numerous studies report an association between RAGE and diabetic complications, with or without the involvement of TLR4, it has been difficult to assign a primary role to this recep tor other than that of a broadspectrum ROS transducer. Ambient or intracellular oxidative stress appears to be an overarching biomodulator of RAGE except when RAGE is genetically manipulated. 114, 115 Thus, a decrease in basal oxidative stress by simply restricting the avail ability of external AGEs is sufficient to suppress both RAGE mRNA and protein levels in diabetic or aging mice. 72, 73 Similarly, AGE restriction reduces RAGE levels in peripheral blood mononuclear cells of healthy humans and of those with diabetes mellitus to levels markedly below their baseline (>60%), which indicates that RAGE is readily regulated by AGEs in the external environment. 21, 88 Of note, RAGE mRNA and protein levels in peripheral blood mono nuclear cells from healthy individuals directly correlate with serum levels of AGEs and oxidative stress, as well as with ingested AGE levels, 21 whereas they are only modest ly elevated in patients with diabetes mellitus without comorbidities. These findings in animals and humans may offer new perspectives on the role of RAGE in diabetes mellitus. Namely, as with other signal trans duction molecules that regulate proinflammatory events, the in vivo upregulation of RAGE may be a result rather than a cause of increased oxidative stress. Once host defenses, including AGER1, are compromised and basal oxidative stress rises, upregulated RAGE may amplify and perpetuate this condition.
Kidneys and AGE clearance
The main 'entry' for foodderived AGEs is the gastro intestinal tract and their main 'exit' is the kidney. Owing to its ability to conserve and also distinguish useful from toxic products-whether from the external or internal environment-the kidney has long been known as a key component of host defenses. The kidney is undoubtedly a major player in the detoxification of AGEs, both by filtra tion or by active uptake and secretion, two processes that result in the net excretion of AGEs in urine. 19, 63, 71, 118 As a consequence of their large blood supply, the kidneys are directly exposed to a larger amount of circulating AGEs than many other organs, a fact which may make them vulnerable to injury by circulating reactive carbonyls and ROS. 119 This process may underlie the early reduction of AGE clearance documented in mice and in patients with diabetes mellitus, before recognizable impairments in renal function occur. 19, 72, 73, 75 Any reduction in renal AGE clearance may potentially cause a buildup of prerenal AGEs and an increase in the formation of new AGEs and ROS within both renal and extrarenal tissues. An early consequence of this process could be the suppression of AGER1 levels, which results in further ROS generation and inflammation. 42 In fact, serum levels of AGEs rise long before any clinical evidence of renal disease mani fests. 20, 120 This factor becomes especially relevant following the onset of diabetes mellitus, given that increased levels of AGEs mediated by hyper glycemia further augment oxidative stress and its pathogenic consequences. 75, 121 Several studies show that chronic ingestion of excess amounts of AGEs can predispose the human kidney to chronic injury in the absence of diabetes mellitus by sup pressing local antiAGE defenses, that is, AGER1, and inducing oxidative stress and inflammatory responses. 20, 21 The presence of diabetes mellitus may aggravate these changes. 19, 21 In support of this view, AGE restriction in mice prevented diabetic or agerelated kidney disease, in spite of persistent hyperglycemia. 72, 73, 75 AGE restriction in humans with diabetic or nondiabetic kidney disease led to decreased serum levels of AGEs, restoration of AGER1 levels and significantly decreased systemic oxidative stress and inflammation. 21, 122 Although functional renal end points are not yet available in humans, a common thread across animal and human studies is emerging: a preexisting oxidant overload may reduce host defenses before the onset of diabetes mellitus and set the stage for diabetic renal disease.
AGEs and diabetes mellitus: a paradigm shift

Animal studies
The unique pathogenic role of AGEs as environmental toxins has been amply supported by studies showing that the parenteral or oral administration of chemically designed AGEs leads to a cycle of increased cell and tissue AGEs, oxidative stress and inflammation in healthy mice. 119, 123 These changes were associated with tissue injury that resembled diabetic vascular or renal complica tions. Of note, these effects were induced without hyper glycemia and could be interrupted by pharmaco logical inhibitors of AGEs. Indeed, although a number of anti AGE and antioxidant agents are effective against diabetic complications in mice, [124] [125] [126] [127] it has yet to be determined whether they can reliably alter the course of sustained glycoxidant overload in humans.
Several studies in humans and animals have suggested the emergence of a paradigm shift in that pathogenic levels of AGEs can be acquired from ingested AGEs, which may be an antecedent rather than the result of hyperglycemia. These studies advanced the postulate that AGEs cause abnormal oxidative stress in the pre diabetic state and that processed nutrients are the principal source of these AGEs. 20, 21, 72, 73 They also demonstrate that oxidant overload and insulin resistance can be diminished 21 and that tissue injury and the development of diabetes mel litus can be prevented in several mouse models by restricting the intake of food AGEs without reducing energy intake. 72, 73, 75, [128] [129] [130] As briefly described below, these studies have provided a new framework and an experi mental setting from which to revisit the pathogenesis and treatment of diabetes mellitus and its complications.
Type 1 diabetes mellitus
Exposure to exogenous AGEs begins in utero. The accrual of AGEs is cumulative with time and could have a role in disease susceptibility to autoimmune T1DM, as well as T2DM. This hypothesis was first tested in a model of autoimmune T1DM, the nonobese diabetic (NOD) mouse. 129 Compared with female NOD controls, over 90% of which became diabetic at ~4-5 months of age, less than Box 2 | AGER1 in the host defense against glycoxidants
The early loss of function of AGER1 caused by sustained external AGE pressure is proposed as the basis of compromised host defenses and increased susceptibility to maladaptive inflammatory processes underlying diabetes mellitus and its complications. ■ AKT activity REVIEWS onethird of NOD mice fed an AGErestricted diet devel oped T1DM. 129 Twothirds remained healthy until study end (12 months). The incidence of T1DM decreased to less than 15% in the next two generations, as long as an AGErestricted diet was maintained in both dams and offspring. The AGErestricted NOD mice had minimal insulitis consistent with reduced stimulation of cytotoxic T cells and macrophages, possibly owing to the restriction of oxidant AGEs in the diet. NOD mice fed a standard chow, which is enriched in AGEs, had the typical hyper responsive, interferonγpositive, but in terleukin4 negative islet T cells that were unresponsive to common islet antigens, such as glutamate decarb oxylase or insulin. The blockade of islet βcell injury in AGErestricted mice suggested that the levels of oxidants in the diet were suf ficient to trigger diabetes mellitus, and this effect was unrelated to the nutrient composition of the diet. Given that diabetes mellitus recurred when offspring were returned to the standard diet, the strong antidiabetic effects of AGE restriction appear to result from retention of a lower basal oxidant stress and, thus, of a normal host defense in this mouse strain that is otherwise genetically susceptible to diabetes mel litus. These findings have been confirmed in vitro and in rodents parenterally adminis tered AGEs and antiAGE agents or an AGErestricted diet (J. M. Forbes, personal communication).
Type 2 diabetes mellitus
The study on AGE restriction in NOD mice was repeated in different animal models of T2DM (leptinreceptor deficient db/db mice, C57B6 mice fed a highfat diet and in C57B6 mice with agerelated T2DM), with analogous results. 72, 73, 128, 130 In each model, AGE restriction led to a decrease in oxidative stress and improved insulin resis tance, even when other traditional risk factors, such as hyperglycemia, obesity, highfat intake, caloric intake or advanced age, were present. Furthermore, AGE restric tion inhibited diabetic renal or vascular complications. 74, 75 The direct toxicity of foodderived AGEs was further sup ported by heattreating or by supplementing a lowAGE diet with methylglyoxalalbumin: both cohorts of mice had an earlyonset of ageassociated insulin resistance and renal disease (H. Vlassara, unpublished work). Mice fed an AGErich diet, as well as mice fed regular mouse chow, had suppressed tissue expression of AGER1, SIRT1, and plasma adiponectin, as well as impaired insulin receptor signaling and low insulinstimulated glucose uptake.
This area of research is currently evolving; however, a unifying observation from these animal models, in which diabetes mellitus was induced by different 'diabetogenic' agents or which had a strong genetic propensity to diabetes mellitus, was that simply reducing the basal (preexisting) oxidative stress by dietary AGE restriction sharply reduced the risk of diabetes mellitus and its complications.
From mice to humans
The recognition of early glucose-protein interactions were initially focused on HbA 1c , seen as a prototype that reflects glycemic control in vivo. 8, 29 This observation was followed by the discovery of the toxicity of late derivatives of these interactions, or AGEs, in the extra cellular and intracellular space of individuals with diabetic complica tions. 29 The efficacy of several AGE inhibitors in reducing diabetic complications in animal models supports the role of these molecules as toxins. 29, 132 However, these comor bidities were predominantly viewed as the consequence of hyperglycemia or aging. 29, [124] [125] [126] [127] 132, 133 The conceptual framework of the toxicity of AGEs underwent a new expansion with the advent of data pointing to the exter nal environment as a source of preformed tissuereactive carbonyls. This new evidence hinted at processes not pre viously associated with AGEs, such as insulin production and insulin sensitivity, which are distinct from and can precede hyperglycemia. 72, 73, [128] [129] [130] Increased oxidative stress, which precedes diabetes mel litus, is evidently a mediator of inflammatory events. This cycle of events, however, could not persist without the prior saturation and neutralization of critical host defenses, such as AGER1. Once AGER1, under exter nal oxidant pressure, is suppressed in tissues, including adipo cytes as well as peripheral blood mononuclear cells, unopposed AGEs may attenuate other key protective mechanisms. Importantly, decreased SIRT1 levels result in continued hyperacetylation of NFκB p65, enhancement of inflammation and a reduction in the metabolic actions of insulin (Figures 2 and 3) . 82, 83 The postulate that AGEs can influence insulin sensiti vity was tested in insulinresistant patients with T2DM exposed to AGE restriction. Compared to the control group, patients on an AGErestricted diet for 4 months had substantial reductions in plasma insulin, leptin, tumor necrosis factor (TNF) and RAGE concentrations and marked increases in adiponectin, AGER1 and SIRT1 levels. These responses were accentuated by monocytic NFκB p65 hyperacetylation, as a result of SIRT1 suppres sion. 88 In addition, gene transfer and silencing studies in monocytelike THP1positve cells provided confirmation that SIRT1 actions are under the control of AGER1 in monocyte and macrophages, where SIRT1 enhances anti inflammatory functions, as well as in adipocytes, where SIRT1 regulates glucose uptake and utilization. 82, 134 Studies on obesity have revealed that changes in insulin target cells are partly owing to inflammatory events arising in adipocytes or from locally recruited immune cells. [134] [135] [136] [137] Tissue macrophages were reported to switch from the common antiinflammatory (M2) phenotype to the proinflammatory phenotype (M1), 138 secreting a variety of chemokines that induce additional inflam matory mediators by insulin target cells via paracrine action. In addition, responses to 'unique' antigens by expanded subpopulations of activated Thelper1 (T H 1) cells that are present in muscle and adipose tissue were shown to promote insulin resistance. 134, [138] [139] [140] On the other hand, antiinflammatory regulatory T cells, which normally attenuate insulin resistance, were found to be decreased in response to these antigens. [140] [141] [142] AGEs are wellknown to be a potent trigger for mono cytes and macrophages, 93, [143] [144] [145] promoting cytokine release and reducing insulin sensitivity. AGEs can also induce Tcell activation and secretion of interferon γ via surface AGE receptors. 145, 146 Thus, a 'preconditioning' of T cells and monocyte populations by orally absorbed AGEs can occur in the circulation before full in situ acti vation, 140, [146] [147] [148] setting the stage for inflammation and insulin resistance. 149 Indeed, the fact that adipose tissue in obesity contains large numbers of macrophages indicates that recruit ment may begin long before insulin resistance is clinically recogn izable. 134 Macrophages, prompted by regulatory T cells, might initially be recruited to adipose tissue for the purpose of clearing stored ALEs and of containing undue inflammation. 141, 142 However, prolonged stimula tion by AGEs of macrophages resident in adipose tissue may result in suppression of AGER1 in macrophages and a shift to the M1 phenotype. This change would promote further ROS formation and a feedforward process of chronic inflammation and insulin resistance, which could lead to diabetes mellitus.
New data suggest that AGEs can also directly impair insulin secretion in pancreatic islet β cells via a number of pathways. For instance, AGEinduced inducible nitric oxide synthase (iNOS) dependent mito chondrial ROS can suppress cytochrome C oxidase and ATP generation, thereby impairing membrane depolarization and imped ing insulin release. 31 Given that AGEs suppress SIRT1, which is also prominent in pancreatic β cells, 150 they may intercept SIRT1 regulation of mitochondrial uncoupling protein 2 (UCP2) and Ca 2+ channel function in β cells, which could suppress insulin secretion (Figure 4 ). 82 Alternatively, as AGEs promote macrophage chemot axis 144 and secretion of TNF and IL1, 143 they may recruit inflammatory cells to islets. Increased IL1 levels are thought to contribute to impaired insulin secretion, decreased cell proliferation and apoptosis in β cells. 151 This view is supported by findings that show a recom binant IL1receptor antagonist improves glycemia and βcell secretory function in patients with T2DM. 152 As these lines of evidence continue to evolve, they remain consistent with the emerging argument that a sustained influx of AGErich nutrients has the potential to suppress innate defense mechanisms and of setting the stage for unopposed oxidative stress in otherwise healthy individuals. The result could be an increase in the basal levels of oxidative stress, which can cause a shift from a normal phenotype to one of depleted antioxidant reserves and, thus, a 'hypersensitivity' to subsequent oxidant chal lenges. This scenario is particularly pertinent to individuals who have a positive energy balance (that is, overnutrition, which promotes obesity) but also applies to nonobese indivi duals with risk factors for diabetes mellitus. 7, 14, 15, 18, 153 This newly appreciated link between AGEs and nutrients may help in understanding how the environment can reduce host defenses and lead to the growing epidemics of the metabolic syndrome and diabetes mellitus.
AGEs: a case for epigenetic change?
The rates of increase in obesity and diabetes mellitus point to a complex and markedly altered interplay between genes and the changing food environment. Whether epigenetic changes could be traced to the increased AGE content of modern food and whether this could play a part in the high incidence of diabetes mellitus was tested in transgenera tional studies in C57B6 mice exposed to an AGErestricted or methylglyoxalsupplemented diet and monitored for five generations (F0 to F5). 118, 154 A striking observation was made in that by the fifth generation, methylglyoxalfed F5mice developed insulin resistance followed by diabetes mellitus at 16-18 months of age, whereas AGErestricted F5mice did not develop these changes until the age of 36 months or more (H. Vlassara, unpublished work). This acceleration of T2DM onset in methylglyoxalfed mice over five generations (by more than onethird of a normal life cycle) could not be attributed to genetic effects, an argument similar to that raised by the doubl ing of obesity in humans within one genera tion. 155 Similarly, this dramatic effect could not be attributed to energy or nutrient intake, as all cohorts were pairfed a nutritionally balanced diet. Rather, the changes represented the effect of a known AGE (methylglyoxal) added to food that other wise had a low AGE content. It was noteworthy that, as tissue AGER1 decreased in a stepwise manner, by the fifth generation serum AGEs in methylglyoxalfed mice were about threefold higher than those in AGErestricted mice, consistent with a gradual rise in the basal oxidative stress transmitted between genera tions. Of note, in the AGE restricted group, the delay or absence of insulin resistance was linked to lower oxidative stress and higher AGER1 levels. Together with data from the transgenerational NOD studies, 129 these findings suggest that the increas ing oxidant burden in the offspring is, on the one hand, determined maternally and, on the other hand, augmented by food oxidants in the postnatal period.
These findings are in agreement with reports that mater nal diet influences disease development, such as obe sity and hypertension in humans and animals. [156] [157] [158] [159] [160] [161] [162] The cross generational loss of function in antiAGE and oxida tive stressregulatory genes could to some degree reflect epigenetic changes owing to the gradual increase in oxidant levels over several generations. Although these data clearly warrant further investigation, it seems probable that impaired host defenses can gradually result in hyper responsiveness to inflammatory stimuli and increased susceptibility to disease. The present studies suggest that changes that result from a dis proportionate increase in oxidants contained in current nutrients may involve heritable changes in gene function, such as those for AGE receptors and sirtuins. The fact that these changes can be modified in mice raises optimism that they may also be controlled in both healthy individuals and in those with diabetes mellitus.
In this context, clinical evidence indicates that circulating AGEs in healthy infants may closely correlate with, and even exceed, maternal or adult AGE levels within the first year of life, 163 which is in line with the above findings in mice. Furthermore, infants born to mothers with high serum AGEs had higher plasma insulin and lower adipo nectin levels, findings which may be the result of the AGE content of heattreated, commercial infant foods, which was found to be ~100fold higher than in maternal breast milk. 164, 165 These alarming facts indicate that, as a result of an exces sive AGE influx, children today may be at risk of altered host defense and immune systems, which may, at least in part, explain the diabetes epidemic. 18, [166] [167] [168] It remains to be seen whether exposure of children to pro cessed foods accounts for the increased incidence of T1DM or T2DM and whether this can be prevented by AGE restriction.
A reversible trend?
Epidemiologic studies show that increased oxidative stress among clinically normal individuals precedes insulin resis tance, T1DM and T2DM. 7, 14, 15, 18, 153 Studies also link high circulating levels of AGEs with prediabetic conditions, such as the metabolic syndrome, cardiac or chronic kidney disease, or frailty of aging. 46, 47, [169] [170] [171] [172] New data have led to practical tools for assessing dietary AGE intake in humans (currently estimated at ~15 Eq or 15 × 10 6 AGE units per day). 42, 173 AGE restriction proved possible and effective based on the simple avoidance of dry heat, namely frying, roasting or broiling methods in food processing, which was accomplished without altering caloric intake. A diet given to healthy indivi duals that contained ~30-50% of the average AGE intake was achieved by employing lower temperature and high moisture methods during the manufacturing process. This approach was effective in lowering circulating AGEs, as well as inflammation and insulin resistance.
Individuals across the age spectrum who consume an AGErich diet may have elevated levels of high sensitivity Creactive protein (hsCRP), TNF, fibrinogen, vascular cell adhesion protein 1 (VCAM1) and HOMA (homeo static model assessment), a predictor of insulin resistance (Box 3). 20, 21, 174 One interpretation of these associations is that modern foods, replete with a ppetiteenhancing AGEs, undermine host defenses, while promoting inflammation. A further interpretation is that the 'healthy' human base line has shifted to a pheno type which displays substantial overlap with 'prediabetes' . In these individuals, the best determinants of systemic AGEs and oxidative stress are dietderived AGEs, rather than glucose, age, sex, calories or nutrient intake. 20, 21 The fact that simply restricting AGE intake, without altering nutrient or caloric intake, can lead to a significant reduction in oxidative stress and inflammatory markers supports the conclusion that AGEs in food are toxins for patients with diabetes mellitus and, importantly, also for healthy individuals.
Serum levels of AGEs are elevated in patients with diabetes mellitus, and their levels predict morbidity and mortality. This concept is not entirely new, 19, 47, 63, [175] [176] [177] but this realization and the data from multiple animal studies prompted new clinical studies that focus on foodderived AGEs and their role in the pathogenesis of insulin resis tance and diabetes mellitus (Box 1 and 3) . A link between food AGEs, inflammation and human diabetes mellitus was initially suggested by the finding that brief AGE restriction (4-6 weeks) in patients with T1DM and T2DM lowered systemic AGE levels, oxidative stress and inflam mation, including TNF, hsCRP and VCAM1 concentra tions. 122 A 4month trial of AGE restriction in patients with wellcontrolled T2DM revealed a ~40% decrease of hyperinsulinemia. 88 The study also reported reduced oxi dative stress and inflammation, including lower plasma leptin, TNF and RAGE levels, and acetylated NFκB p65 in mononuclear cells. A marked recovery was noted in levels of AGER1, SIRT1 and adiponectin, three factors with antiinflammatory properties that were decreased at baseline. As the return of innate defenses to normal levels resulted in decreased inflammation and insulin resistance, 134 this strategy carries promise as an efficient, lowcost treatment for those with diabetes mellitus or with prediabetes. 6, 7, [15] [16] [17] [18] 88, 153, 166 Importantly, sevelamer-an oral nonabsorbable nega tively charged polymer that, in addition to phosphates, can sequester AGEs in the gut-offers critical support to the benefits of AGE restriction. Within 2 months, sevelamer, but not CaCO 3 -a phosphatebinder that does not bind AGEs-effectively lowered serum AGE levels, markers of oxidative stress and inflammation, and restored levels of AGER1 and SIRT1 in patients with early diabetic nephro pathy (H. Vlassara and G. E. Striker, unpublished work). This alternative approach confirms the significance of reducing oral AGE absorption.
Modification of dietary habits requires education and legislative action in order to restrict foods rich in AGEs, label foods with AGE content and promote AGE restric tion as a strategy to help stem the diabetes epidemic and its complications. A strategy aimed at screening for and advising those with high levels of AGE markers or dietary consumption may be a first move in this direction.
Conclusions
The current diabetes epidemic is unarguably a result of environmental changes. A major shift over the past half century is the enrichment of nutrients by AGEs, highly palatable and appetiteenhancing, prooxidant substances that simultaneously drive overnutrition and oxidant overload. Sustained oxidant overload may overwhelm host defenses and raise basal levels of oxidative stress, presaging chronic inflammation. These states can impair both insulin production and insulin sensitivity and lead to diabetes mellitus. Evidence from trans generational animal studies and human trials indicates that high basal oxidative stress, which precedes both T1DM and T2DM, is the result of externally derived, as well as maternally transmitted, AGEs. Altered host defenses may amount to epigenetic changes-a possibility that is worthy of indepth investigation.
Efforts to curtail the current diabetes epidemic must address and reduce the preexisting elevated basal oxida tive stress and inflammation in order to prevent, improve or reverse diabetes mellitus. Randomized, controlled clinical studies are needed to confirm and expand on the notion that AGE restriction is a promising, costeffective clinical intervention to achieve these goals.
Review criteria
A search for original articles published between 1970 and 2010 and focusing on diabetes mellitus was performed in MEDLINE and PubMed. The search terms used were "T1D", "T2D", "environment", "oxidant stress", "inflammation", "diabetogenic agents", "innate immunity", "host defense", "insulin resistance", "AGEs", "AGE-receptors" and "diabetic complications". All articles identified were English-language or French-language, full-text papers. We also searched the reference lists of identified articles for further papers.
